Clinical Trials Logo

Behavior Disorders clinical trials

View clinical trials related to Behavior Disorders.

Filter by:

NCT ID: NCT04675567 Recruiting - Behavior Disorders Clinical Trials

The Safety-Net Approach

Safety-Net
Start date: March 17, 2021
Phase: N/A
Study type: Interventional

The Safety-Net project, is intended to disrupt disparities in mental health treatment access for children at-risk for childhood trauma (ACEs) and/or serious emotional disturbance (SED). "Safety Net" will use mobile clinical and family support teams to improve mental health outcomes. This clinical innovation, nested in an integrated system-of-care will be piloted for children, ages 3-18 yrs., with SED who receive primary care through Cambridge Health Alliance.

NCT ID: NCT04185896 Recruiting - Depression Clinical Trials

Perinatal Mental Health Care in Switzerland

MADRE
Start date: July 10, 2019
Phase:
Study type: Observational

This qualitative study with quantitative elements examines the health care provided to women who suffered from mental disorder during pregnancy and / or in the first year after birth (i.e. during the perinatal phase). Investigators will perform individual interviews with former PMD patients, and health and social care professionals to gain insights into current health care for PMD patients.

NCT ID: NCT03904784 Terminated - Depression Clinical Trials

School Withdrawal in Adolescents

DESCOL
Start date: March 21, 2019
Phase:
Study type: Observational

The aim of the study is to evaluate the impact of the outpatient ambulatory child psychiatric care system on the functioning of anxio-depressive adolescents in school retreat by describing the modalities of individual psychic functioning.

NCT ID: NCT03835689 Active, not recruiting - Clinical trials for Neurodevelopmental Disorders

Strongest FamiliesTM Neurodevelopmental

Start date: April 8, 2019
Phase: N/A
Study type: Interventional

Children and adolescents with neurodevelopmental conditions are 3 to 5 times more likely than their peers to have other mental disorders such as anxiety, depression and disruptive behaviour. Furthermore, these conditions are less likely to be recognized, diagnosed and treated than for typically developing children. Parent training is a well-established approach to help parents change their behaviour and communication with their children with the goal of improving child behaviours. Parent-focused programs that are designed for typically developing children have shown mixed results for children with neurodevelopmental conditions and parents have reported significant challenges in accessing traditional health services due to barriers to care. There is an urgent need to explore how effective distance-delivered parenting programs can be implemented in real-world settings and how they should be adapted to meet the needs of families with children with neurodevelopmental conditions. The goal of this research project is to develop and test the effectiveness of two versions (group coaching & self-managed) of an online parenting program for managing challenging behaviours in children with neurodevelopmental disabilities. The Strongest Families Neurodevelopmental program is based on the well-established Strongest Families Parenting program for typically developing children with challenging behaviours, adapted with substantial involvement from a pan-Canadian Parent Advisory Committee. The program consists of 11 skill-based sessions with demonstration videos, audio clips, exercises, a resource webpage and a Parent-to-Parent online group (a closed Facebook group).

NCT ID: NCT03817710 Not yet recruiting - Behavior Disorders Clinical Trials

Tics in Childern With Acute Deficit Hyper Activity Syndrom

Start date: October 1, 2019
Phase:
Study type: Observational

Tics have been defined as sudden, rapid, recurrent, non-rhythmic, stereotyped, involuntary movements or vocalizations. Motor tic can be either simple or complex, depending on whether one or several muscle groups are simultaneously or concurrently affected. Motor tics commonly include behaviours such as eye blinking, lip-licking, or mouth opening. It can also involve more complex movements like facial grimacing ,head movements , shoulder shrugging or combinations of these.Vocal or phonic tics are involuntary sounds that include throat clearing, coughing, barking, sniffing, unnecessary belching or more complex vocalizations such as repeating parts of words or phrases. Gilles de la Tourette's syndrome is complex neurodevelopmental disorder characterized by combination of motor and vocal tics. Motor tics often precede the onset of phonic tics by many years. The phonic tics may commence from about the age of 3 years. Severe Tourette's Syndrome may manifest as forceful bouts of self-harming motor tics, including hitting or biting, as well as socially unacceptable utterances (coprolalia) and gestures [3]. The Tourette's Syndrome Study Group definition from 1993 requires the concurrent presence of motor and vocal tics occurring almost daily for at least one year, [4]. The Diagnostic and Statistical Manual of Mental Disorders 5th Edition requires both multiple motor and one or more vocal tics have been present at some time during the illness, although not necessarily concurrently for the diagnosis of Tourette's Syndrome . It also describes Tics Disorder and Tourette's Syndrome as waxing and waning in frequency and symptoms must have lasted for more than one year since the first onset.

NCT ID: NCT03799783 Completed - Procedural Sedation Clinical Trials

The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders

Start date: March 1, 2018
Phase: Phase 2
Study type: Interventional

Children's compliance during diagnostic or therapeutic procedures is a challenge, often requiring the use of sedative and/or analgesic drugs. Electroencephalogram (EEG) needs stillness for a medium-long period but, at the same time, the use of any drug for sedation may affect the exam through an interference with EEG waves. Dexmedetomidine is a selective ∝2-adrenergic agonist with sedative and anxiolytic properties, with a long effect and which does not alter EEG pattern. The aim of this interventional study is to evaluate the effectiveness, safety and feasibility of dexmedetomidine for sedation during EEG in children who are not cooperative. Children affected by behavioral disorders and requiring sedation to perform EEG were considered. The protocol establishes to administer IV dexmedetomidine (loading dose and continued infusion) to reach a targeted level of sedation (Pediatric Sedation State Scale = 2). Vital signs (SatO2, RR, EtCO2, HR, BP) and level of sedation are recorded before, during and after procedure until the offset.

NCT ID: NCT03736057 Completed - Dementia Clinical Trials

Genetic Evaluation for Medication Selection (GEMS) Study

GEMS
Start date: May 13, 2016
Phase:
Study type: Observational

Investigators propose to determine whether knowing details about how a person's genes affect the way medicines work in the brain and body will help doctors pick more effective or safer medicine for that person. Target symptoms are restlessness, agitation, depression and related problems common in people with memory loss and dementia.

NCT ID: NCT03614026 Completed - Behavior Disorders Clinical Trials

Teachers and Parents as Partners During Middle School RCT

Start date: September 30, 2018
Phase: N/A
Study type: Interventional

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facilitators to implementing Teachers and Parents as Partners in middle school for students with behavior concerns.

NCT ID: NCT03485898 Terminated - Behavior Disorders Clinical Trials

Study of Patients Hospitalized in Specialized Cognitive-behavioral Unit (UCC)

UCC
Start date: April 12, 2018
Phase:
Study type: Observational

The purpose of the study is to assess the mortality of patient discharged from the specialized cognitive-behavioral unit (UCC) of Toulon.

NCT ID: NCT03483896 Completed - Depression Clinical Trials

Pilot Study to Examine Health Effects of Daylight Exposure on Dementia Patients

Start date: January 30, 2017
Phase: N/A
Study type: Interventional

This study is designed to test the hypothesis that an intervention increasing exposure to daylight indoors will reduce depression and other neuropsychiatric symptoms among people living with dementia in long term care facilities.